EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation

Tang-Her Jaing iD, Yi-Lun Wang iD, Chia-Chi Chiu

Viruses · 2024

DOI: 10.3390/v16081268 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Viruses, 2024. Verfasst von Tang-Her Jaing und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 33315, Taiwan. Hauptthemen laut MEDLINE: Antiviral Agents, Cytomegalovirus, Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This systematic review discusses the use of prophylaxis to prevent cytomegalovirus (CMV) infection in recipients who have undergone hematopoietic cell transplantation. It highlights the need for new approaches to control and prevent CMV infection. The approval of the anti-CMV drug letermovir has made antiviral prophylaxis more popular. CMV-specific T cell-mediated immunity tests are effective in identifying patients who have undergone immune reconstitution and predicting disease progression. Maribavir (MBV) has been approved for the treatment of post-transplant CMV infection/disease in adolescents. Adoptive T-cell therapy and the PepVax CMV vaccine show promise in tackling refractory and resistant CMV. However, the effectiveness of PepVax in reducing CMV viremia/disease was not demonstrated in a phase II trial. Cell-mediated immunity assays are valuable for personalized management plans, but more interventional studies are needed. MBV and adoptive T-cell therapy are promising treatments, and trials for CMV vaccines are ongoing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsCytomegalovirusCytomegalovirus InfectionsHematopoietic Stem Cell TransplantationHumansCytomegalovirus VaccinesDichlororibofuranosylbenzimidazoleT-Lymphocytes

Stichwörter der Autor:innen

allogeneic hematopoietic cell transplantationantiviral agentscytomegaloviruspediatric

Substanzen

Antiviral AgentsCytomegalovirus VaccinesDichlororibofuranosylbenzimidazolemaribavir

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 33315, Taiwan.
  • Division of Nursing, Chang Gung Memorial Hospital, Taoyuan 33315, Taiwan.

ORCID-Profile: Tang-Her Jaing, Yi-Lun Wang

Zitieren

APA

Jaing, T. H., Wang, Y. L., & Chiu, C. C. (2024). Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation. Viruses. https://doi.org/10.3390/v16081268

Vancouver

Jaing TH, Wang YL, Chiu CC. Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation. Viruses. 2024. doi:10.3390/v16081268

BibTeX
@article{Jaing2024,
  author = {Jaing, Tang-Her and Wang, Yi-Lun and Chiu, Chia-Chi},
  title = {Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16081268}
}
Kostenlos starten →